Citation Impact
Citing Papers
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Diverse Effects of Nanosecond Pulsed Electric Fields on Cells and Tissues
2003
Guidelines for the welfare and use of animals in cancer research
2010 Standout
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
2020
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Cancer immunotherapy: the beginning of the end of cancer?
2016
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
2012
Oral Administration of 3,3’-Diindolylmethane Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells in BALB/c Mice1–3
2009
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Ganoderma – A therapeutic fungal biofactory
2006 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
2009
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP)
2017 StandoutNobel
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
The IKK-related kinases: from innate immunity to oncogenesis
2008
Hepatocellular carcinoma
2021 Standout
Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents
2005
Microfluidic platforms for RNA interference screening of virus–host interactions
2013
Adenovirus Evasion of Interferon-Mediated Innate Immunity by Direct Antagonism of a Cellular Histone Posttranslational Modification
2012
Virus-mediated gene delivery for human gene therapy
2012
Oncolytic viruses: a new class of immunotherapy drugs
2015
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
2015
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Replication-selective oncolytic viruses in the treatment of cancer
2004
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
2017
Going viral with cancer immunotherapy
2014
Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I
2009
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
2019
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Non-coding RNAs in human disease
2011 Standout
Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100
2002
Recent progress in the battle between oncolytic viruses and tumours
2005
Regulation of type I interferon responses
2013 Standout
Intracellular trafficking of nonviral vectors
2005
Microbubble Stability is a Major Determinant of the Efficiency of Ultrasound and Microbubble Mediated in vivo Gene Transfer
2009 StandoutNobel
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
2017
Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency
2014
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
2005 StandoutNobel
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
Understanding and altering cell tropism of vesicular stomatitis virus
2013
The PI3K Pathway in Human Disease
2017 Standout
High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation
2005
Shape effects of filaments versus spherical particles in flow and drug delivery
2007 Standout
Oncolytic virotherapy
2012
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Oncolytic adenoviruses – selective retargeting to tumor cells
2005
ATP-Dependent Effector-like Functions of RIG-I-like Receptors
2015 StandoutNobel
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
2009
Oncolytic Vesicular Stomatitis Virus Induces Apoptosis via Signaling through PKR, Fas, and Daxx
2006
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Management of glioblastoma: State of the art and future directions
2020 Standout
A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo
2008
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
2015
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Plasma medicine: an introductory review
2009 Standout
Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals
2004
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
2017
Transcriptional control of human p53-regulated genes
2008 Standout
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Variable Deficiencies in the Interferon Response Enhance Susceptibility to Vesicular Stomatitis Virus Oncolytic Actions in Glioblastoma Cells but Not in Normal Human Glial Cells
2006
Evolution of Oncolytic Viruses: Novel Strategies for Cancer Treatment
2013
Oncolytic Newcastle Disease Virus for Cancer Therapy: Old Challenges and New Directions
2012
Efficient nonviral gene delivery into primary lymphocytes from rats and mice
2006
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma
2010
Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
2018
Nanosecond, high‐intensity pulsed electric fields induce apoptosis in human cells
2003 Standout
Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis
2012
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma
2005
Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
2009
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides
2005
Works of Oliver Ebert being referenced
MODULATION OF CELL SURFACE MARKERS ON NK-LIKE T LYMPHOCYTES BY USING IL-2, IL-7 OR IL-12 IN VITRO STIMULATION
2000
STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma
2015
Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice
2004
Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
2009
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
2008
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12
1998
Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
2007
Inhibition of the IFN-β Response in Hepatocellular Carcinoma by Alternative Spliced Isoform of IFN Regulatory Factor-3
2008
Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma
2010
Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
2001
Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV
2005
Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent mice
2003
Lymphocyte apoptosis: induction by gene transfer techniques
1997
Oncolysis of Multifocal Hepatocellular Carcinoma in the Rat Liver by Hepatic Artery Infusion of Vesicular Stomatitis Virus
2004
Interleukin‐12 Expression Enhances Vesicular Stomatitis Virus Oncolytic Therapy in Murine Squamous Cell Carcinoma
2007
rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
2008
Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats.
2003
Posttranslational Modification of Vesicular Stomatitis Virus Glycoprotein, but Not JNK Inhibition, Is the Antiviral Mechanism of SP600125
2012
Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
2011
Syncytia Induction Enhances the Oncolytic Potential of Vesicular Stomatitis Virus in Virotherapy for Cancer
2004
Fusogenic Vesicular Stomatitis Virus for the Treatment of Head and Neck Squamous Carcinomas
2007
TNF-alpha secretion and apoptosis of lymphocytes mediated by gene transfer.
1999
Prophylactic Alpha Interferon Treatment Increases the Therapeutic Index of Oncolytic Vesicular Stomatitis Virus Virotherapy for Advanced Hepatocellular Carcinoma in Immune-Competent Rats
2005
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma
2018
Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses
2011